KWMG
YARW

King Wealth Management Group’s Yarrow Bioscience YARW Stock Holding History

King Wealth Management Group’s Portfolio YARW Stock Details YARW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-3
Closed -$19K – 167
2020
Q3 		$19K Hold
3
– – ﹤0.01% 158
2020
Q2 		$20K Buy
+3
New +$20.3K 0.01% 152

Other funds holding YARW

PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
DA
DSC Advisors Chicago, Illinois $11M AUM 5.88% 1-Year Est. Return
Axa
Axa Paris, France $91.9M AUM 27.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
DAM
Deltec Asset Management New York $677M AUM 31.67% 1-Year Est. Return

King Wealth Management Group's YARW Position: Q4 2020 in Review

King Wealth Management Group sold out of Yarrow Bioscience (YARW) in Q4 2020, closing a stake of 3 shares — an estimated $19K sold.

King Wealth Management Group first reported a position in YARW in Q2 2020 and held it in 2 quarters. The position peaked at $20K in Q2 2020. 98 funds tracked by Wall St. Rank hold YARW as of Q4 2020.

  • King Wealth Management Group reported no remaining Yarrow Bioscience position as of Q4 2020 after selling out during the quarter.
  • King Wealth Management Group sold 3 Yarrow Bioscience shares in Q4 2020, an estimated $19K.
  • King Wealth Management Group first reported a position in Yarrow Bioscience in Q2 2020 and held it in 2 quarters.
  • King Wealth Management Group's Yarrow Bioscience position peaked at $20K in Q2 2020.
  • 98 funds tracked by Wall St. Rank held Yarrow Bioscience as of Q4 2020.

Based on King Wealth Management Group's 13F filing for Q4 2020, filed 12 Feb 2021.